These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8158337)

  • 1. Association between smoking and micro-albuminuria in hypertensive patients with type 2 diabetes mellitus.
    Corradi L; Zoppi A; Tettamanti F; Malamani G; Lazzari P; Fogari R
    J Hypertens Suppl; 1993 Dec; 11(5):S190-1. PubMed ID: 8158337
    [No Abstract]   [Full Text] [Related]  

  • 2. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal disease by type 2 diabetes].
    Persson F; Rossing P
    Ugeskr Laeger; 2012 Sep; 174(37):2150-4. PubMed ID: 22971295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
    Chuahirun T; Khanna A; Kimball K; Wesson DE
    Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
    Eijkelkamp WB; Zhang Z; Remuzzi G; Parving HH; Cooper ME; Keane WF; Shahinfar S; Gleim GW; Weir MR; Brenner BM; de Zeeuw D
    J Am Soc Nephrol; 2007 May; 18(5):1540-6. PubMed ID: 17409317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Routine screening for microalbuminemia in type 2 diabetes mellitus--con].
    Sawicki PT
    Dtsch Med Wochenschr; 2003 May; 128(21):1188. PubMed ID: 12761693
    [No Abstract]   [Full Text] [Related]  

  • 8. [Routine screening for microalbuminemia in type 2 diabetes mellitus--pro].
    Dikow R; Ritz E
    Dtsch Med Wochenschr; 2003 May; 128(21):1187. PubMed ID: 12761692
    [No Abstract]   [Full Text] [Related]  

  • 9. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 10. Albuminuria in non-insulin-dependent diabetes mellitus. Prevalence, causes, and consequences.
    Gall MA
    Dan Med Bull; 1997 Nov; 44(5):465-85. PubMed ID: 9408734
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK; Chaturvedi N; Fuller J
    Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand.
    Buranakitjaroen P; Deerochanawong C; Bunnag P
    J Med Assoc Thai; 2005 Nov; 88(11):1624-9. PubMed ID: 16471111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
    Bakris GL; Toto RD; McCullough PA
    J Hum Hypertens; 2005 Feb; 19(2):139-44. PubMed ID: 15457206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO; Coll JR; Tran ZV; Schrier RW
    Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Charlton-Menys V; DeMicco DA; Fuller JH;
    Am J Kidney Dis; 2009 Nov; 54(5):810-9. PubMed ID: 19540640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A; Amer W; Anwar E; Bashir K
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):429-35. PubMed ID: 19414946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of the Dipstick Micraltest II in the screening of microalbuminuria of diabetes mellitus type 2 and essential hypertension.
    Cortés-Sanabria L; Martínez-Ramírez HR; Hernández JL; Rojas-Campos E; Canales-Muñoz JL; Cueto-Manzano AM
    Rev Invest Clin; 2006; 58(3):190-7. PubMed ID: 16958293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes.
    Chuahirun T; Simoni J; Hudson C; Seipel T; Khanna A; Harrist RB; Wesson DE
    Am J Med Sci; 2004 Feb; 327(2):57-67. PubMed ID: 14770020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.